1180 Maximizing NK cell immunotherapy in prostate cancer via TriKEs

Samankaltaisia teoksia

• 1180 Maximizing NK cell immunotherapy in prostate cancer via TriKEs
  Tekijä: Joshua Walker, et al.
  Julkaistu: (2023-11-01)
• 161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
  Tekijä: Dhifaf Sarhan, et al.
  Julkaistu: (2018-06-01)
• Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA
  Tekijä: Felix Oh, et al.
  Julkaistu: (2023-06-01)
• BiTEs, DARTS, BiKEs and TriKEs—Are Antibody Based Therapies Changing the Future Treatment of AML?
  Tekijä: Cecily Allen, et al.
  Julkaistu: (2021-05-01)
• 365 Oxygen levels found in bone marrow (5%) provide an optimal niche for the differentiation of induced-pluripotent stem cell-derived NK cells for the treatment of AML
  Tekijä: Jeffrey S Miller, et al.
  Julkaistu: (2023-11-01)